Interim Management

Change is natural in an evolving environment, so drug development companies are frequently facing dynamic periods of transition, challenge or change. This may be due to changes of the strategic direction, a portfolio expansion or the development of the company. Start-up biotech companies may require additional expertise for their development plans or to establish their operational business to manage the R2D transition and early clinical phase, while companies at a later clinical stage may need to quickly fill a position to launch or proceed with priority projects in a timely manner.

If your company requires management support for any reason, be it medium-term or in the long run, I can help by assuming interim management roles to complement your leadership team:

• Line management roles (COO, VP Operations, Head of Clinical Operations, Head of QM, or similar functions).
• Team enablement: building up and leading cross-functional teams from pre-clinical to phase III.